Related Experiment Video
Updated: Jul 14, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells
F Flamigni1, I Stanic', A Facchini
1Department of Biochemistry "G. Moruzzi", University of Bologna, Bologna, Italy. flavio.flamigni@unibo.it
Abstract:
Growing evidence suggests a role for polyamines in apoptosis, although the relationship appears to be complex. alpha-Difluoromethylornithine (DFMO), a largely used ornithine decarboxylase inhibitor, is cytostatic, hardly cytotoxic and may even increase the resistance of tumour cells to some apoptotic stimuli. This may represent a problem in cancer therapy, where the killing of tumoral cells would be a desired effect, but could be an advantage in other pathological contexts related to an excess of apoptosis, such as cardiovascular diseases, stem cell transplantation, arthritis and infections. In different cellular models, polyamine depletion following treatment with polyamine biosynthesis inhibitors appears to inhibit mitochondrial and death receptor pathways of apoptosis by affecting key proteins. These studies indicate that inhibition of polyamine biosynthesis may prevent or reduce the apoptotic response triggered by a variety of stimuli in non-tumoral cells, such as cardiac cells, stem cells, chondrocytes, macrophages and intestinal epithelial cells.
Insights
Polyamines influence apoptosis, with alpha-difluoromethylornithine (DFMO) inhibiting cell death in non-cancerous cells. This polyamine inhibition may offer therapeutic benefits in conditions involving excessive apoptosis.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Polyamines play a complex role in apoptosis.
- Alpha-difluoromethylornithine (DFMO), an ornithine decarboxylase inhibitor, is cytostatic and can enhance tumor cell resistance to apoptosis.
- This dual effect presents challenges in cancer therapy but potential benefits in other diseases.
Purpose of the Study:
- To investigate the role of polyamine biosynthesis inhibition in apoptosis.
- To explore the potential therapeutic applications of polyamine depletion in non-tumoral contexts.
Main Methods:
- Utilized cellular models to study the effects of polyamine biosynthesis inhibitors.
- Assessed the impact of polyamine depletion on mitochondrial and death receptor apoptosis pathways.
- Examined the modulation of key proteins involved in apoptosis.
Main Results:
- Polyamine depletion, induced by inhibitors like DFMO, was shown to inhibit apoptosis in various non-tumoral cell types.
- This inhibition affects both the mitochondrial and death receptor pathways.
- Key apoptotic proteins were modulated by polyamine depletion.
Conclusions:
- Inhibition of polyamine biosynthesis can prevent or reduce apoptosis in non-tumoral cells, including cardiac cells, stem cells, chondrocytes, macrophages, and intestinal epithelial cells.
- This finding suggests potential therapeutic strategies for diseases characterized by excessive apoptosis.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:55Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Related Concept Videos
The Intrinsic Apoptotic Pathway
Biosynthesis of Nucleic Acids
Abnormal Proliferation
Apoptosis
The Extrinsic Apoptotic Pathway